Sanofi announced today that it has signed an agreement to acquire Genfar S.A., a leading pharmaceuticals manufacturer headquartered in Bogota, Colombia. Genfar S.A. is the second largest generic company in sales and leader in units in Colombia and has a commercial presence in Venezuela, Peru, Ecuador and ten other countries in Latin America. In 2011, Genfar’s total sales were USD 133 million, with 30% of sales generated outside of Colombia.
No comments:
Post a Comment
Please share your views to enrich the discussion